Table 1

Overarching principles and points to consider for including the perspective of young patients with IA into PROMs

Overarching principlesLoA
Mean (SD)
AIA has a considerable impact on all aspects of the life of young people, and PROMs are useful to measure part of this impact9.69 (±0.63),
100%≥8
BThe value of PROMs is optimised when young people with IA are informed and empowered9.92 (0.28),
100%≥8
CPROMs are useful when integrated in the communication between young people with IA and rheumatologists/other health professionals who are involved in their care.9.77 (0.44),
100%≥8
DPROMs inform shared decision-making for young people with IA.9.31 (0.18),
92%≥8
Points to considerLoEStrength of recommendationLoA
Mean (SD)
1Young people with IA should be informed about the purpose and relevance of PROMs.5D9.85 (0.37),
100%≥8
2Young people with IA should have the possibility to access their personal PROM data.5D9.31 (1.18),
85%≥8
3Healthcare providers and young people with IA should discuss the results of PROMs and integrate them into shared decision making.5D9.78 (0.44),
100%≥8
4Different PROMs assess various domains and should therefore be used to cover a broad spectrum of the disease.5D9.15 (1.82),
85%≥8
5Healthcare providers should ascertain the willingness of young people with IA to talk about issues such as body image and life plans, and discuss these domains respecting the patients’ preferences.5D9.54 (1.13),
92%≥8
6The assessment of a young person with IA should encompass items and domains of his/her daily life such as psychosocial issues, participation in social activities, education/work, sports and using technologic devices.5C9.46 (1.20),
92%≥8
7The schedule of PROMs assessment should be agreed on by the healthcare provider and the young person with IA, to balance frequency versus inconvenience.5D9.46 (1.05),
92%≥8
8Online and e-solutions for PROMs should be used when possible and convenient for young people with IA.5D9.92 (0.28),
100%≥8
  • Numbers in the column ‘LoA’ indicate the mean (SD) of the LoA, and the percentage of task force members with a LoA of at least 8 (0–10); based on the Oxford Centre for Evidence-Based Medicine classification

  • IA, inflammatory arthritis; LoA, level of agreement; LoE, level of evidence; PROMs, patient-reported outcome measures.